We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+8.59%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$19.2B
AUM Growth
+$1.55B
Cap. Flow
+$290M
Cap. Flow %
1.51%
Top 10 Hldgs %
20.86%
Holding
1,746
New
188
Increased
838
Reduced
420
Closed
42

Sector Composition

Rank Sector Weight
1 Technology 24.37%
2 Healthcare 17.03%
3 Consumer Discretionary 14.96%
4 Financials 12.56%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANDE icon
1651
Andersons Inc
ANDE
$2.23B
$272K ﹤0.01%
+8,923
New +$269K
HY icon
1652
Hyster-Yale Materials Handling
HY
$614M
$270K ﹤0.01%
+3,700
New +$287K
SPHR icon
1653
Sphere Entertainment
SPHR
$6.29B
$269K ﹤0.01%
3,200
-200
-6% -$17.7K
JRVR icon
1654
James River Group Holdings
JRVR
$199M
$268K ﹤0.01%
7,137
+500
+8% +$20K
ALX
1655
Alexander's
ALX
$1.39B
$266K ﹤0.01%
+993
New +$275K
BLUE
1656
DELISTED
bluebird bio
BLUE
$266K ﹤0.01%
643
-324
-34% -$128K
DESP
1657
DELISTED
Despegar.com
DESP
$266K ﹤0.01%
+20,100
New +$271K
PLUS icon
1658
ePlus
PLUS
$2.32B
$266K ﹤0.01%
+6,144
New +$293K
KLRS
1659
Kalaris Therapeutics
KLRS
$93.7M
$265K ﹤0.01%
+583
New +$301K
CPA icon
1660
Copa Holdings
CPA
$5.54B
$264K ﹤0.01%
3,500
-1,800
-34% -$145K
MDGL icon
1661
Madrigal Pharmaceuticals
MDGL
$12.4B
$263K ﹤0.01%
2,700
+300
+13% +$35.5K
ICPT
1662
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$263K ﹤0.01%
+13,165
New +$261K
RTL
1663
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$263K ﹤0.01%
31,052
+13,400
+76% +$125K
TEVA icon
1664
Teva Pharmaceuticals
TEVA
$42.8B
$262K ﹤0.01%
26,500
CHRS icon
1665
Coherus Oncology
CHRS
$181M
$260K ﹤0.01%
18,800
+8,600
+84% +$122K
JBLU icon
1666
JetBlue
JBLU
$2.18B
$260K ﹤0.01%
15,500
-24,000
-61% -$465K
OMER icon
1667
Omeros
OMER
$992M
$257K ﹤0.01%
17,300
+2,300
+15% +$38.6K
GBIO
1668
DELISTED
Generation Bio
GBIO
$256K ﹤0.01%
+950
New +$284K
TRHC
1669
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$250K ﹤0.01%
+5,000
New +$224K
PTVE
1670
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$249K ﹤0.01%
+16,500
New +$248K
LRN icon
1671
Stride
LRN
$3.27B
$247K ﹤0.01%
7,700
ENTA icon
1672
Enanta Pharmaceuticals
ENTA
$393M
$242K ﹤0.01%
+5,500
New +$269K
KRON
1673
DELISTED
Kronos Bio
KRON
$242K ﹤0.01%
+10,100
New +$256K
IGMS
1674
DELISTED
IGM Biosciences
IGMS
$241K ﹤0.01%
+2,900
New +$215K
AIV
1675
Aimco
AIV
$379M
$240K ﹤0.01%
35,748
+4,300
+14% +$29.6K

Similar funds

Handelsbanken Fonder's Q2 2021 Portfolio in Review

As of Q2 2021, Handelsbanken Fonder held 1,746 positions worth $19.2B, up 8.8% from $17.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Handelsbanken Fonder's Q2 2021 filing shows 188 new, 838 increased, 420 reduced and 42 closed positions. Its largest new stake was Vimeo: 570,772 shares worth $28M. The largest sale was Nuance Communications, Inc., an estimated $73M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q2 2021 buy was Vimeo: 570,772 shares worth $28M.
  • Handelsbanken Fonder added most to Evoqua Water Technologies Corp. Common Stock in Q2 2021, an estimated $34.3M increase.
  • Handelsbanken Fonder's biggest Q2 2021 reduction was Nuance Communications, Inc., cutting an estimated $73M.
  • Handelsbanken Fonder fully exited GE Aerospace in Q2 2021, selling an estimated $28.2M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $19.2B portfolio in Q2 2021.
  • Handelsbanken Fonder opened 188 new positions and closed 42 in Q2 2021.
  • Handelsbanken Fonder's portfolio value rose 8.8% quarter-over-quarter to $19.2B.

Based on Handelsbanken Fonder's 13F filing for Q2 2021, filed 3 Aug 2021.